Scientists Develop a New Approach That Reduces the Failure Rate In Drug Development

As reported in Science Daily, researchers at the University of Bristol’s MRC Epidemiology Unit working with pharmaceutical companies have developed an approach to reduce the failure rate of developing drugs.…

Continue Reading Scientists Develop a New Approach That Reduces the Failure Rate In Drug Development
September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
source: pixabay.com

September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness

September 15th, 2020 is recognized as World Lymphoma Awareness Day. This day is dedicated to spreading awareness about lymphoma and falls in the context of Blood Cancer Awareness Month, which…

Continue Reading September 15th is World Lymphoma Awareness Day: Spreading Blood Cancer Awareness
September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
source: pixabay.com

September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness

This year, September 13-19 is being recognized as Balance Awareness Week. Organized by the Vestibular Disorders Association, the goal of this campaign is to help spread awareness among both the…

Continue Reading September 13-19 is Balance Awareness Week: Spreading Vestibular Disorders Awareness
Study Says Asian Patients With NAFLD Have Lower Risk of Cirrhosis
https://pixabay.com/illustrations/scale-weigh-in-mass-weight-scales-1133910/

Study Says Asian Patients With NAFLD Have Lower Risk of Cirrhosis

This past week, Target RWE announced data from its TARGET-NASH study, designed to better understand differences in health outcomes for patients with nonalcoholic fatty liver disease (NAFLD). According to their…

Continue Reading Study Says Asian Patients With NAFLD Have Lower Risk of Cirrhosis
Experimental Glioblastoma Treatment Earns Orphan Drug Designation
source: pixabay.com

Experimental Glioblastoma Treatment Earns Orphan Drug Designation

According to a story from BioSpace, the drug company Plus Therapeutics has recently announced that its investigational therapy Rhenium NanoLiposomes (RNL™) has earned Orphan Drug designation from the US Food…

Continue Reading Experimental Glioblastoma Treatment Earns Orphan Drug Designation

Editor’s Choice: Balance Awareness Week and Study Updates

Happy Friday! Sept. 13-19 is Balance Awareness Week. It's intended to bring attention to balance-related vestibular disorders such as Meniere’s disease and vestibular migraine. Looking for ways to help out?…

Continue Reading Editor’s Choice: Balance Awareness Week and Study Updates

Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…

Continue Reading Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases
Habit Cough: An Unusual Form of Chronic Cough That Can be Cured Over Zoom
source: pixabay.com

Habit Cough: An Unusual Form of Chronic Cough That Can be Cured Over Zoom

Bethany Buettner had started coughing...a lot. She had recently faced pneumonia, but after a course of antibiotics she appeared to have recovered...except for her persistent cough. It wasn't long before…

Continue Reading Habit Cough: An Unusual Form of Chronic Cough That Can be Cured Over Zoom
Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial
source: pixabay.com

Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial

According to a story from Pharmaceutical Business Review, the pharmaceutical company Bayer has recently announced encouraging findings from its phase 4 clinical study. This trial was testing the drug riociguat…

Continue Reading Pulmonary Arterial Hypertension Drug Adempas Achieves Primary Endpoint in Recent Trial

Could Psilocybin Become The First Pharmaceutical to Treat Methamphetamine Use Disorder?

As reported in Biospace, the life sciences company Revive Therapeutics Ltd. has announced their intention to join a Clinical Trial Agreement (CTA) with the Board of Regents of the University of…

Continue Reading Could Psilocybin Become The First Pharmaceutical to Treat Methamphetamine Use Disorder?
An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals, Inc. has announced recently that its experimental diagnostic 64Cu-SARTATE™ has earned Rare Pediatric Disease designation from the US Food…

Continue Reading An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation
AChR Antibodies and C5a Protein are MG Severity Biomarkers
kalhh / Pixabay

AChR Antibodies and C5a Protein are MG Severity Biomarkers

To determine disease progression and severity, researchers often use biomarkers, a measurable substance that indicates disease state. According to Myasthenia Gravis News, a new study shows that acetylcholine receptor (AChR)…

Continue Reading AChR Antibodies and C5a Protein are MG Severity Biomarkers

New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Ionis Pharmaceuticals has just released their findings from a study investigating the effect of IONIS-PKK-LRx and IONIS-PKKRx in hereditary angioedema (HAE) patients with different forms of the disease. These therapies work to reduce…

Continue Reading New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Study Finds New Therapy to be Efficacious for Rheumatoid Arthritis Patients Unresponsive to Methotrexate

A new study published in the journal Rheumatology and Therapy examined the effect of baricitinib on Rheumatoid Arthritis (RA) patients who have had an inadequate to their methotrexate therapy. Methotrexate and Baricitinib…

Continue Reading Study Finds New Therapy to be Efficacious for Rheumatoid Arthritis Patients Unresponsive to Methotrexate

Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers

Researchers in Canada have just released positive results from their heterozygous familial hypercholesterolemia (HeFH) clinical trial. This investigation was examining the effect of Repatha on teenagers with the condition. The trial…

Continue Reading Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
GRIN Disorder: Don’t Miss the CureGRIN Foundation’s GRIN Virtual Conference
source: pixabay.com

GRIN Disorder: Don’t Miss the CureGRIN Foundation’s GRIN Virtual Conference

The CureGRIN Foundation has recently announced that its annual conference will be held virtually this year as a result of the ongoing coronavirus/COVID-19 pandemic. This year's event will be held…

Continue Reading GRIN Disorder: Don’t Miss the CureGRIN Foundation’s GRIN Virtual Conference
Close Menu